TY - JOUR
T1 - Interleukin-1 beta inhibition with canakinumab and reducing lung cancer鈥攕ubset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS)
JO - Journal of Thoracic Disease
UR - https://doi.org/10.21037/jtd.2018.07.50
PY - 2018/09/01
AU - Crossman D
AU - Rothman AMK
ED -
DO - DOI: 10.21037/jtd.2018.07.50
PB - AME Publishing Company
VL - 10
IS - S26
SP - S3084
EP - S3087
Y2 - 2025/07/28
ER -